Overcoming Barriers to Clinical Trial Enrollment
Clinical trials are imperative for testing novel cancer therapies, advancing the science of cancer care, and determining the best treatment strategies to enhance outcomes for patients with cancer.
Research
Subsidizing Health Insurance for Low-Income Adults: Evidence from Massachusetts
How much are low-income individuals willing to pay for health insurance, and what are the implications for insurance markets?
Data-Driven Percentile Optimization for Multi-Class Queueing Systems with Model Ambiguity: Theory and Application
Multiclass queueing systems widely used in operations research and management typically experience ambiguity in real-world settings in the form of unknown parameters.
Parent Preferences for Health Outcomes Associated with Autism Spectrum Disorders
Few studies have used preference-based quality-of-life outcomes to assess how autism spectrum disorders (ASDs) affect children and parents, and none have examined variation by ASD severity.
Adjusted Mortality Rates Are Lower For Medicare Advantage Than Traditional Medicare, But The Rates Converge Over Time
Overall mortality rates, adjusted for age, sex, and Medicaid status, in Medicare Advantage have been below those in traditional Medicare for many years.
Technological Progress and Health Convergence: The Case of Penicillin in Post-War Italy
Throughout history, technological progress has transformed population health, but the distributional effects of these gains are unclear.
Typhoid Conjugate Vaccines: A New Tool in the Fight against Antimicrobial Resistance
Typhoid fever is an acute systemic infectious disease responsible for an estimated 12–20 million illnesses and over 150?000 deaths annually.
The Orphan Drug Act at 35: Observations and an Outlook for the Twenty-First Century
On the thirty-fifth anniversary of the adoption of the Orphan Drug Act (ODA), we describe the enormous changes in the markets for therapies for rare diseases that have emerged over recent decades.
Behavioral Economics and Health-Care Markets
This chapter summarizes research in behavioral health economics, focusing on insurance markets and product markets in health care.
Alma-Ata at 40 Years: Reflections from the Lancet Commission on Investing in Health
The 40th anniversary of the Alma-Ata Declaration gave the Lancet Commission on Investing in Health an opportunity to assess progress towards grand convergence, and to reflect on the future of primary
Get smart & reliable public policy insights right in your inbox.